Daniel Cooperman - Molina Healthcare Non-Executive Independent Director
| MOH Stock | USD 296.60 0.00 0.00% |
Director
Mr. Daniel Cooperman is the NonExecutive Independent Director of Molina Healthcare, Inc. He Served as Chairman of the audit committee and member of the Board of Directors of Zoox, Inc., a young robotics company developing a fully autonomous vehicle, since 2015. Member of the Board of Directors of LegalZoom.Com, Inc. from 2012 until its change of control in 2014 member of the Board of Directors of Nanoscale Components Inc., a lithium ion technology company, since 2012. ExChairman and member of the Board of Directors of Second Harvest Food Bank of Santa Clara and San Mateo Counties, since 2010. Member of the Board of Directors of Liffey Thames Group, LLC dba Discovia, a legal services company, from 2011 to 2017. Of Counsel, DLA Piper LLP, a global law firm, from December 2014 to November 2016. Of Counsel, Bingham McCutchen, LLP, a global law firm, from 2010 to 2014. Senior Vice President, Secretary, and General Counsel of Apple Inc. from 2007 to 2009. Senior Vice President, Secretary, and General Counsel of Oracle Corporation from 1997 to 2007. Partner, McCutchen, Doyle, Brown Enersen, LLP from 1977 to 1997. Distinguished Visiting Lecturer, Stanford Law School since 2010. Fellow, Arthur and Toni Rembe Rock Center for Corporationrationrate Governance, Stanford Law School and Graduate School of Business since 2012. Juris Doctorate, Stanford Law School. MBA, Stanford Graduate School of Business. Graduated Dartmouth College, summa cum laude, with an A.B. in Economics with highest distinction since 2013.
| Age | 70 |
| Tenure | 11 years |
| Professional Marks | MBA |
| Address | 200 Oceangate, Long Beach, CA, United States, 90802 |
| Phone | 562 435 3666 |
| Web | https://www.molinahealthcare.com |
Molina Healthcare Management Efficiency
The company has Return on Asset of 0.069 % which means that on every $100 spent on assets, it made $0.069 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2645 %, implying that it generated $0.2645 on every 100 dollars invested. Molina Healthcare's management efficiency ratios could be used to measure how well Molina Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The Molina Healthcare's current Return On Capital Employed is estimated to increase to 0.43, while Return On Tangible Assets are projected to decrease to 0.07. As of now, Molina Healthcare's Non Current Assets Total are increasing as compared to previous years. The Molina Healthcare's current Non Currrent Assets Other is estimated to increase to about 104.9 M, while Other Assets are forecasted to increase to (40.9 M).Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Gail Wilensky | UnitedHealth Group Incorporated | 76 | |
| Frank DAmelio | Humana Inc | 63 | |
| NancyAnn DeParle | CVS Health Corp | 64 | |
| Mark McClellan | Cigna Corp | 57 | |
| Orlando Ayala | Centene Corp | 64 | |
| Alecia DeCoudreaux | CVS Health Corp | 66 | |
| Tony White | CVS Health Corp | 73 | |
| John Partridge | Cigna Corp | 71 | |
| Valerie Rice | UnitedHealth Group Incorporated | 58 | |
| Roger Farah | CVS Health Corp | 68 | |
| David Jones | Humana Inc | 71 | |
| Roman Martinez | Cigna Corp | 71 | |
| Richard Gephardt | Centene Corp | 79 | |
| Siddhartha Sankaran | Oscar Health | 46 | |
| Timothy Flynn | UnitedHealth Group Incorporated | 64 | |
| Frank Bisignano | Humana Inc | 62 | |
| William Weldon | CVS Health Corp | 72 | |
| Michele Hooper | UnitedHealth Group Incorporated | 68 | |
| JeanPierre Millon | CVS Health Corp | 70 | |
| Marissa Peterson | Humana Inc | 58 | |
| Eric Foss | Cigna Corp | 62 | |
Management Performance
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.069 |
Molina Healthcare Leadership Team
Elected by the shareholders, the Molina Healthcare's board of directors comprises two types of representatives: Molina Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Molina. The board's role is to monitor Molina Healthcare's management team and ensure that shareholders' interests are well served. Molina Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Molina Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph CFA, Senior Relations | ||
| Jason Dees, Executive Vice President - Marketplace | ||
| James Woys, Executive Vice President - Health Plan Services | ||
| Maurice CPA, Chief Officer | ||
| Garrey Carruthers, Independent Director | ||
| Brian Maddy, President - Oklahoma | ||
| FAAFP DO, Executive Officer | ||
| Joseph Zubretsky, President, Chief Executive Officer, Director | ||
| David Reynolds, Senior Plans | ||
| Esq JD, Chief Sec | ||
| Thomas Tran, Chief Financial Officer, Treasurer | ||
| John Kotal, Chief California | ||
| Richard Zoretic, Independent Director | ||
| Dale Wolf, Non-Executive Independent Director | ||
| Maurice Hebert, Chief Accounting Officer | ||
| Mark Keim, Executive Vice President - Executive Vice President Strategic Planning, Corporate Development & Transformation | ||
| Jeffrey Geyer, Head Relations | ||
| Stephen Lockhart, Independent Director | ||
| Barbara Brasier, Independent Director | ||
| Richard Schapiro, Independent Director | ||
| Jeff Barlow, Senior Vice President General Counsel, Secretary | ||
| Joann ZarzaGarrido, Vice Compliance | ||
| Dave Reynolds, Senior Vice President - Health Plans | ||
| Keith Wilson, Chief Officer | ||
| Daniel Cooperman, Non-Executive Independent Director | ||
| Ronna Romney, Independent Vice Chairman of the Board | ||
| Larry Anderson, Executive Officer | ||
| David Pollack, VP Operations | ||
| Marc Russo, Executive Vice President - Medicaid Health Plans | ||
| Keith MD, Chief Officer | ||
| Steven Orlando, Independent Director |
Molina Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Molina Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.069 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 10.36 B | ||||
| Shares Outstanding | 57.2 M | ||||
| Shares Owned By Insiders | 1.13 % | ||||
| Shares Owned By Institutions | 99.89 % | ||||
| Number Of Shares Shorted | 997.36 K | ||||
| Price To Earning | 26.49 X |
Currently Active Assets on Macroaxis
When determining whether Molina Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Molina Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Molina Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Molina Healthcare Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Molina Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Molina Stock please use our How to Invest in Molina Healthcare guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molina Healthcare. If investors know Molina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molina Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.342 | Earnings Share 19.65 | Revenue Per Share 649.831 | Quarterly Revenue Growth 0.174 | Return On Assets 0.069 |
The market value of Molina Healthcare is measured differently than its book value, which is the value of Molina that is recorded on the company's balance sheet. Investors also form their own opinion of Molina Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Molina Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molina Healthcare's market value can be influenced by many factors that don't directly affect Molina Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Molina Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Molina Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molina Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.